Boai NKY Medical Holdings Ltd. (300109.SZ)
CNY 17.2
(6.57%)
CNY 17.2
(6.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -230.36 Million CNY | 51.22% |
| 2022 | -472.28 Million CNY | 55.58% |
| 2021 | -1.06 Billion CNY | -298.49% |
| 2020 | 535.59 Million CNY | -17.93% |
| 2019 | 652.62 Million CNY | 49.92% |
| 2018 | 435.32 Million CNY | 161.79% |
| 2017 | 166.28 Million CNY | 187.98% |
| 2016 | -189 Million CNY | 9.41% |
| 2015 | -208.63 Million CNY | -1106.85% |
| 2014 | -17.28 Million CNY | 15.58% |
| 2013 | -20.47 Million CNY | 52.49% |
| 2012 | -43.1 Million CNY | 60.82% |
| 2011 | -110.02 Million CNY | 48.83% |
| 2010 | -215.01 Million CNY | -8432.36% |
| 2009 | 2.58 Million CNY | -77.23% |
| 2008 | 11.33 Million CNY | 130.66% |
| 2007 | 4.91 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 96.94 Million CNY | -46.07% |
| 2024 Q1 | -195.52 Million CNY | 15.12% |
| 2024 Q2 | 179.76 Million CNY | 191.94% |
| 2023 Q2 | -199.68 Million CNY | 52.1% |
| 2023 Q4 | -230.36 Million CNY | 3.75% |
| 2023 Q1 | -416.91 Million CNY | 11.72% |
| 2023 FY | -230.36 Million CNY | 51.22% |
| 2023 Q3 | -239.34 Million CNY | -19.86% |
| 2022 Q4 | -472.28 Million CNY | -19.67% |
| 2022 Q3 | -394.66 Million CNY | -10.78% |
| 2022 Q1 | -711.79 Million CNY | 33.05% |
| 2022 Q2 | -356.27 Million CNY | 49.95% |
| 2022 FY | -472.28 Million CNY | 55.58% |
| 2021 Q2 | 381.08 Million CNY | -25.97% |
| 2021 FY | -1.06 Billion CNY | -298.49% |
| 2021 Q1 | 514.74 Million CNY | -3.89% |
| 2021 Q3 | 466.17 Million CNY | 22.33% |
| 2021 Q4 | -1.06 Billion CNY | -328.05% |
| 2020 FY | 535.59 Million CNY | -17.93% |
| 2020 Q3 | 629.94 Million CNY | -3.53% |
| 2020 Q2 | 653 Million CNY | -4.52% |
| 2020 Q1 | 683.89 Million CNY | 4.79% |
| 2020 Q4 | 535.59 Million CNY | -14.98% |
| 2019 Q2 | 584.59 Million CNY | 3.4% |
| 2019 Q4 | 652.62 Million CNY | 12.23% |
| 2019 FY | 652.62 Million CNY | 49.92% |
| 2019 Q1 | 565.38 Million CNY | 29.88% |
| 2019 Q3 | 581.49 Million CNY | -0.53% |
| 2018 Q4 | 435.32 Million CNY | -2.68% |
| 2018 FY | 435.32 Million CNY | 161.79% |
| 2018 Q3 | 447.32 Million CNY | -3.47% |
| 2018 Q1 | 459.47 Million CNY | 176.32% |
| 2018 Q2 | 463.38 Million CNY | 0.85% |
| 2017 Q3 | -111.91 Million CNY | 16.63% |
| 2017 Q1 | -137.8 Million CNY | 27.09% |
| 2017 Q2 | -134.23 Million CNY | 2.59% |
| 2017 FY | 166.28 Million CNY | 187.98% |
| 2017 Q4 | 166.28 Million CNY | 248.58% |
| 2016 Q3 | -155.19 Million CNY | -365.41% |
| 2016 Q2 | 58.47 Million CNY | -54.78% |
| 2016 Q4 | -189 Million CNY | -21.78% |
| 2016 FY | -189 Million CNY | 9.41% |
| 2016 Q1 | 129.31 Million CNY | 161.98% |
| 2015 Q1 | -12.29 Million CNY | 28.9% |
| 2015 FY | -208.63 Million CNY | -1106.85% |
| 2015 Q2 | -5.61 Million CNY | 54.35% |
| 2015 Q3 | -183.94 Million CNY | -3178.08% |
| 2015 Q4 | -208.63 Million CNY | -13.42% |
| 2014 Q2 | -13.95 Million CNY | -50.98% |
| 2014 FY | -17.28 Million CNY | 15.58% |
| 2014 Q4 | -17.28 Million CNY | -164.11% |
| 2014 Q3 | -6.54 Million CNY | 53.09% |
| 2014 Q1 | -9.24 Million CNY | 54.87% |
| 2013 Q3 | -27.38 Million CNY | -40.44% |
| 2013 Q1 | -24.68 Million CNY | 42.74% |
| 2013 FY | -20.47 Million CNY | 52.49% |
| 2013 Q4 | -20.47 Million CNY | 25.23% |
| 2013 Q2 | -19.5 Million CNY | 20.99% |
| 2012 Q2 | -61.57 Million CNY | 33.74% |
| 2012 FY | -43.1 Million CNY | 60.82% |
| 2012 Q1 | -92.92 Million CNY | 15.54% |
| 2012 Q4 | -43.1 Million CNY | -5.9% |
| 2012 Q3 | -40.7 Million CNY | 33.89% |
| 2011 Q2 | -181.63 Million CNY | 6.41% |
| 2011 Q3 | -134.11 Million CNY | 26.16% |
| 2011 FY | -110.02 Million CNY | 48.83% |
| 2011 Q4 | -110.02 Million CNY | 17.96% |
| 2011 Q1 | -194.07 Million CNY | 9.74% |
| 2010 Q3 | -223.56 Million CNY | -1281.78% |
| 2010 Q2 | 18.91 Million CNY | 29.98% |
| 2010 FY | -215.01 Million CNY | -8432.36% |
| 2010 Q4 | -215.01 Million CNY | 3.83% |
| 2010 Q1 | 14.55 Million CNY | 464.02% |
| 2009 Q4 | 2.58 Million CNY | 0.0% |
| 2009 FY | 2.58 Million CNY | -77.23% |
| 2008 FY | 11.33 Million CNY | 130.66% |
| 2007 FY | 4.91 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 935.92 Million CNY | 124.614% |
| Zhejiang Zhenyuan Share Co., Ltd. | -320.75 Million CNY | 28.181% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 580.71 Million CNY | 139.669% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 520.61 Million CNY | 144.249% |
| Yifan Pharmaceutical Co., Ltd. | 1.29 Billion CNY | 117.764% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | -129.14 Million CNY | -78.384% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.88 Billion CNY | 107.997% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -562.43 Million CNY | 59.041% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | -1.1 Billion CNY | 79.226% |